Trials / Conditions / Systemic Light Chain Amyloidosis
Systemic Light Chain Amyloidosis
4 registered clinical trials studyying Systemic Light Chain Amyloidosis — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain A NCT07266116 | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis NCT07151690 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Recruiting | The Impact of Systemic Light Chain Amyloidosis on Eyes NCT06803082 | Zhongshan Ophthalmic Center, Sun Yat-sen University | — |
| Completed | A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis NCT01789242 | Criterium, Inc. | Phase 1 |